FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1163567007: Belumosudil mesilate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4597372013 Belumosudil mesilate en Synonym Active Entire term case insensitive SNOMED CT core module
4597373015 Belumosudil mesilate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
4597374014 Belumosudil mesylate en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belumosudil mesilate Is a Heterocyclic compound true Inferred relationship Existential restriction modifier
Belumosudil mesilate Is a Substance with Rho-associated protein kinase inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Belumosudil mesilate Has disposition Rho-associated protein kinase inhibitor true Inferred relationship Existential restriction modifier
Belumosudil mesilate Is modification of Belumosudil true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely belumosudil (as belumosudil mesilate) 200 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Belumosudil mesilate Inferred relationship Existential restriction modifier 1
Belumosudil 200mg tablets Has specific active ingredient True Belumosudil mesilate Inferred relationship Existential restriction modifier
Rezurock 200mg tablets (Sanofi) 30 tablet Has specific active ingredient True Belumosudil mesilate Inferred relationship Existential restriction modifier
Belumosudil 200mg tablets 30 tablet Has specific active ingredient True Belumosudil mesilate Inferred relationship Existential restriction modifier
Rezurock 200mg tablets (Sanofi) Has specific active ingredient True Belumosudil mesilate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start